Active Ingredient: BEMPEDOIC ACID; EZETIMIBE
Proprietary Name: NEXLIZET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 180MG;10MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211617
Product Number: 001
Approval Date: Feb 26, 2020
Applicant Holder Full Name: ESPERION THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
